| Announce Date | 10/29/2025 |
| EPS Normalized Actual | $0.86 (Beat by $0.45) |
| EPS GAAP Actual | $0.86 (Beat by $0.45) |
| Revenue Actual | $0.1753B |
| Revenue Surprise | Beat by $175.3M |
| Announce Date | 10/01/2025 (Pre-Market) |
| EPS Normalized Estimate | $0.95 |
| EPS GAAP Estimate | $0.95 |
| Revenue Estimate | $0.19895B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Dec 2027 | 5.01 | 9.17 | 4.96686 | 5.05234 | 1 |
| Dec 2026 | 3.56 | 12.91 | 3.54126 | 3.57529 | 1 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | -1.49 | -3.1 | 0.1753B | -2.4% | -79.7M |
| FQ2 2025 (Jun 2025) | 1.3 | 1.3 | 0.2181B | -11.28% | -50.4M |
| FQ1 2025 (Mar 2025) | 1.08 | 1.08 | 0.2011B | -1.14% | -19.1M |
| FQ4 2024 (Dec 2024) | 0.22 | 0.22 | 0.1563B | -12.92% | 156.3M |
| FQ3 2024 (Sep 2024) | 0.3 | 0.3 | 0.1795B | -0.28% | 179.5M |
| FQ2 2024 (Jun 2024) | 1.5 | 1.5 | 0.2427B | 0.25% | 242.7M |
| FQ1 2024 (Mar 2024) | 1.14 | 1.14 | 0.2034B | 2.36% | 203.4M |
| FQ4 2023 (Dec 2023) | 0.37 | 0.37 | 0.1765B | 4.99% | 176.5M |
FQ4 Announce Date
10/01/2025 (Pre-Market)
Consensus EPS Estimates
0.95
Consensus Revenue Estimates
0.19895B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 0 | -- | 0 | 0 | 0 |
| FQ3 2027 (Sep 2027) | 0 | -- | 0 | 0 | 1 |
| FQ2 2027 (Jun 2027) | 0 | -- | 0 | 0 | 1 |
| FQ1 2027 (Mar 2027) | 0 | -- | 0 | 0 | 0 |
| FQ4 2026 (Dec 2026) | 0 | -- | 0 | 0 | 0 |
| FQ3 2026 (Sep 2026) | 0 | INF | 0 | 0 | 0 |
| FQ2 2026 (Jun 2026) | 0 | -INF | 0 | 0 | 0 |
| FQ1 2026 (Mar 2026) | 0 | -INF | 0 | 0 | 0 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 0.18B | -- | 0.17B | 0.19B | 2 |
| FQ3 2027 (Sep 2027) | 0.19B | -- | 0.19B | 0.19B | 2 |
| FQ2 2027 (Jun 2027) | 0.24B | -- | 0.24B | 0.24B | 2 |
| FQ1 2027 (Mar 2027) | 0.22B | -- | 0.21B | 0.23B | 2 |
| FQ4 2026 (Dec 2026) | 0.19B | -- | 0.19B | 0.19B | 1 |
| FQ3 2026 (Sep 2026) | 0.19B | 7.8 | 0.19B | 0.19B | 1 |
| FQ2 2026 (Jun 2026) | 0.26B | 15.48 | 0.26B | 0.26B | 1 |
| FQ1 2026 (Mar 2026) | 0.22B | 6.83 | 0.22B | 0.22B | 1 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
7
EPS # of Misses
1
EPS # of in-lines
0
Revenue # of Beats
5
Revenue # of Misses
3
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 1.61 | -1.49 | -3.1 | 208.05% |
| FQ2 2025 (Jun 2025) | 0 | 1.3 | 1.3 | 100% |
| FQ1 2025 (Mar 2025) | 0 | 1.08 | 1.08 | 100% |
| FQ4 2024 (Dec 2024) | 0.22 | 0.22 | 100% | |
| FQ3 2024 (Sep 2024) | 0.3 | 0.3 | 100% | |
| FQ2 2024 (Jun 2024) | 1.5 | 1.5 | 100% | |
| FQ1 2024 (Mar 2024) | 1.14 | 1.14 | 100% | |
| FQ4 2023 (Dec 2023) | 0.37 | 0.37 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | $0.26B | $0.18B | $-79.7M | -45.46% |
| FQ2 2025 (Jun 2025) | $0.27B | $0.22B | $-50.4M | -23.11% |
| FQ1 2025 (Mar 2025) | $0.22B | $0.2B | $-19.1M | -9.5% |
| FQ4 2024 (Dec 2024) | $0B | $0.16B | $156.3M | 100% |
| FQ3 2024 (Sep 2024) | $0B | $0.18B | $179.5M | 100% |
| FQ2 2024 (Jun 2024) | $0B | $0.24B | $242.7M | 100% |
| FQ1 2024 (Mar 2024) | $0B | $0.2B | $203.4M | 100% |
| FQ4 2023 (Dec 2023) | $0B | $0.18B | $176.5M | 100% |